1′-cyano nucleoside analogs and uses thereof Grant US-11939347-B2 United States of America 26 Mar 2024
Compounds and methods for treatment of viral infections Grant US-11926645-B2 United States of America 12 Mar 2024
1′-cyano nucleoside analogs and methods for treatment of viral infections Grant US-11851438-B2 United States of America 26 Dec 2023
Compounds and methods for treatment of viral infections Grant US-11845755-B2 United States of America 19 Dec 2023
Compounds and methods for treatment of viral infections Grant US-11814406-B2 United States of America 14 Nov 2023
Compounds and methods for treatment of viral infections Grant US-11780844-B2 United States of America 10 Oct 2023
Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs Grant US-11701372-B2 United States of America 18 Jul 2023
Methods for the prophylaxis and treatment of Covid and Covid-19 Application GB-2613460-A United Kingdom 07 Jun 2023
COVID-19 THERAPEUTIC AGENT AND USE OF COMPOUND FOR PRODUCING COVID-19 THERAPEUTIC AGENT Application WO-2022250100-A1 World Intellectual Property Organisation (WIPO) 01 Dec 2022
ANTIVIRAL AGENTS Application WO-2022049288-A1 World Intellectual Property Organisation (WIPO) 10 Mar 2022
REMDESIVIR TREATMENT METHODS Application WO-2021243157-A1 World Intellectual Property Organisation (WIPO) 02 Dec 2021
CORONAVIRUS INFECTION THERAPEUTIC AGENT FORMED THROUGH COMBINATION OF PYRAZINE DERIVATIVE… Application WO-2021221043-A1 World Intellectual Property Organisation (WIPO) 04 Nov 2021
METHODS FOR THE PROPHYLAXIS AND TREATMENT OF COVID AND COVID-19 Application WO-2021216385-A1 World Intellectual Property Organisation (WIPO) 28 Oct 2021
METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING CORONAVIRUS… Application WO-2021209740-A1 World Intellectual Property Organisation (WIPO) 21 Oct 2021
VIRAL INFECTION THERAPEUTIC Application WO-2021182597-A1 World Intellectual Property Organisation (WIPO) 16 Sep 2021